Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023
10 Agosto 2023 - 3:05PM
Business Wire
Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology
company focused on acquiring, developing, and commercializing
innovative therapeutics that transform patients’ lives, announced
that Dirk Thye, M.D., the company’s Chief Executive Officer, will
present at the Sidoti Virtual Investor Conference on Thursday,
August 17, 2023, at 3:15 p.m. Eastern Time (12:15 p.m. Pacific
Time).
A live webcast of the investor presentation will be accessible
on the Events page under the News & Events heading of Quince’s
Investor Relations website at ir.quincetx.com. An archive of the
webcast will be available shortly following the end of the live
event.
About Quince Therapeutics
Quince Therapeutics is a biotechnology company focused on
acquiring, developing, and commercializing innovative therapeutics
that transform the lives of patients suffering from debilitating
and rare diseases. For more information, visit www.quincetx.com and
follow Quince Therapeutics on LinkedIn and @Quince_Tx on
Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230810799693/en/
Quince Therapeutics Contact: Stacy Roughan Quince
Therapeutics, Inc. Vice President, Corporate Communications &
Investor Relations ir@quincetx.com
Quince Therapeutics (NASDAQ:QNCX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Quince Therapeutics (NASDAQ:QNCX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
